Dawnrays Pharmaceutical's issued shares rise slightly from option exercises

Dawnrays Pharmaceutical (Holdings) Limited announced its monthly return on movements in securities for September 2025, revealing a slight expansion in its issued share capital. The total number of issued ordinary shares increased by 120,000 to 1,503,357,000 from the previous month's 1,503,237,000. This increase was primarily due to the exercise of share options from the 2013 Share Option Scheme.

The company's authorised/registered share capital remained constant at 20,000,000,000 ordinary shares with a par value of HK$0.05, totaling HK$1,000,000,000. The exercise of 120,000 share options from the 2013 scheme resulted in HK$108,000 in funds raised during the month.

As of September 30, 2025, 8,828,000 share options remained outstanding under the 2013 scheme, with 7,556,000 shares available for issuance. Additionally, 16,000,000 share options were outstanding under the 2023 Share Option Scheme, with 133,970,500 shares available for future issuance upon exercise.